Related references
Note: Only part of the references are listed.Statin Use and Risk of Diabetes Mellitus in Postmenopausal Women in the Women's Health Initiative
Annie L. Culver et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study
Xia Sheng et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2012)
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Joep Perk et al.
EUROPEAN HEART JOURNAL (2012)
Is the Use of Cholesterol-Lowering Drugs for the Prevention of Cardiovascular Complications in Type 2 Diabetics Evidence-Based? A Systematic Review
Michel de Lorgeril et al.
REVIEWS ON RECENT CLINICAL TRIALS (2012)
Are statins diabetogenic?
Uchechukwu K. Sampson et al.
CURRENT OPINION IN CARDIOLOGY (2011)
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis
David Preiss et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Rosuvastatin-Associated Adverse Effects and Drug-Drug Interactions in the Clinical Setting of Dyslipidemia
Michael S. Kostapanos et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2010)
Mechanisms Underlying Pleiotropic Effects of Statins
Chandrasekar Palaniswamy et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Differing effect of statins on insulin sensitivity in non-diabetics: A systematic review and meta-analysis
William L. Baker et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Balancing the benefits of statins versus a new risk-diabetes
Christopher P. Cannon
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil N. Rajpathak et al.
DIABETES CARE (2009)
Adverse Effects of Statins - Mechanisms and Consequences
Jerzy Beltowski et al.
CURRENT DRUG SAFETY (2009)
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials
Craig I. Coleman et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
LANCET (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug-induced endocrine and metabolic disorders
Ronald C. W. Ma et al.
DRUG SAFETY (2007)
Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control
M. Nakata et al.
DIABETOLOGIA (2006)
Statins: Beneficial or adverse for glucose metabolism
Jun Sasaki et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2006)
Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997-2003
T Walley et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Statins and newly diagnosed diabetes
SS Jick et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
S Wild et al.
DIABETES CARE (2004)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Share Paper
